LACEY WILLS: Open Payments
NPI 1275135212 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$398 in 20 payments from 10 companies in 2025. Trend: 2023 $746 · 2024 $549 · 2025 $398
Food & beverage: $398
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $93 |
| Novo Nordisk Inc | 4 | $70 |
| Astellas Pharma US Inc | 2 | $61 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Dexcom, Inc. | 1 | $28 |
| Boston Scientific Corporation | 1 | $21 |
| CooperSurgical, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $17 |
Products named: Veozah, QULIPTA, Wegovy, TRELEGY ELLIPTA, Dexcom G6 Transmitter, WATCHMAN FLX, Paragard T 380A, VRAYLAR.
Industry payments across KY — which companies pay providers there.
